Dentsply International Inc. (XRAY) Stock Price Down 2.5%
Shares of Dentsply International Inc. (NASDAQ:XRAY) dropped 2.5% during mid-day trading on Thursday . The stock traded as low as $63.42 and last traded at $63.53, with a volume of 1,234,649 shares trading hands. The stock had previously closed at $65.14.
XRAY has been the subject of several research reports. Credit Suisse Group AG reissued a “buy” rating on shares of Dentsply International in a research report on Sunday, June 5th. Barrington Research reissued an “outperform” rating and issued a $68.00 price target (up previously from $62.00) on shares of Dentsply International in a research report on Friday, May 13th. Zacks Investment Research downgraded shares of Dentsply International from a “hold” rating to a “sell” rating in a research report on Monday, April 11th. Piper Jaffray Cos. reaffirmed a “buy” rating on shares of Dentsply International in a report on Monday, June 27th. Finally, Morgan Stanley reaffirmed a “hold” rating and set a $65.00 price objective on shares of Dentsply International in a report on Monday, May 9th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $66.50.
The company has a 50 day moving average price of $62.87 and a 200-day moving average price of $60.99. The firm has a market cap of $14.52 billion and a P/E ratio of 30.14.
Dentsply International (NASDAQ:XRAY) last announced its earnings results on Friday, August 5th. The company reported $0.76 EPS for the quarter, beating analysts’ consensus estimates of $0.70 by $0.06. During the same quarter in the prior year, the company earned $0.73 EPS. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. Dentsply International’s revenue was up 46.4% compared to the same quarter last year. On average, equities analysts predict that Dentsply International Inc. will post $2.75 earnings per share for the current fiscal year.
In other Dentsply International news, VP Rainer Berthan sold 6,464 shares of the stock in a transaction on Thursday, June 2nd. The stock was sold at an average price of $62.56, for a total value of $404,387.84. Following the completion of the transaction, the vice president now owns 39,341 shares in the company, valued at $2,461,172.96. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Michael C. Alfano sold 3,000 shares of the stock in a transaction on Thursday, May 26th. The stock was sold at an average price of $61.58, for a total value of $184,740.00. Following the completion of the transaction, the director now owns 8,758 shares of the company’s stock, valued at approximately $539,317.64. The disclosure for this sale can be found here.
Other institutional investors have recently bought and sold shares of the company. Suntrust Banks Inc. increased its position in Dentsply International by 56.4% in the fourth quarter. Suntrust Banks Inc. now owns 19,214 shares of the company’s stock worth $1,169,000 after buying an additional 6,930 shares during the period. Atlantic Trust Group LLC purchased a new position in Dentsply International during the fourth quarter worth about $1,350,000. GSA Capital Partners LLP increased its position in Dentsply International by 77.3% in the fourth quarter. GSA Capital Partners LLP now owns 22,250 shares of the company’s stock worth $1,354,000 after buying an additional 9,700 shares during the period. Advisors Asset Management Inc. increased its position in Dentsply International by 4.2% in the fourth quarter. Advisors Asset Management Inc. now owns 24,738 shares of the company’s stock worth $1,505,000 after buying an additional 992 shares during the period. Finally, Aberdeen Asset Management PLC UK increased its position in Dentsply International by 18.2% in the fourth quarter. Aberdeen Asset Management PLC UK now owns 25,917 shares of the company’s stock worth $1,519,000 after buying an additional 3,982 shares during the period.
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.